BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17873720)

  • 1. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma.
    Tsai JC; Song BJ; Wu L; Forbes M
    J Glaucoma; 2007 Sep; 16(6):567-71. PubMed ID: 17873720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of erythropoietin in neuroprotection: therapeutic perspectives.
    Grasso G; Sfacteria A; Meli F; Passalacqua M; Fodale V; Buemi M; Giambartino F; Iacopino DG; Tomasello F
    Drug News Perspect; 2007 Jun; 20(5):315-20. PubMed ID: 17878959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contemporary possibilities and perspectives in the treatment of glaucoma].
    Czepita D
    Ann Acad Med Stetin; 2005; 51(1):27-31. PubMed ID: 16496599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
    Neufeld AH
    Brain Res Bull; 2004 Feb; 62(6):455-9. PubMed ID: 15036557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in stroke: quo vadis.
    Digicaylioglu M
    Expert Opin Biol Ther; 2010 Jun; 10(6):937-49. PubMed ID: 20394473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in neuroprotection.
    Whitcup SM
    Prog Brain Res; 2008; 173():323-35. PubMed ID: 18929119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the development of glaucoma neuroprotection therapy.
    Liu Y; Pang IH
    Cell Tissue Res; 2013 Aug; 353(2):253-60. PubMed ID: 23474740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and neuroprotection: a therapeutic perspective.
    Milano M; Collomp R
    J Oncol Pharm Pract; 2005 Dec; 11(4):145-9. PubMed ID: 16595066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular protection by erythropoietin: new therapeutic implications?
    Joyeux-Faure M
    J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of glaucoma as a neurodegenerative disease.
    Jutley G; Luk SM; Dehabadi MH; Cordeiro MF
    Neurodegener Dis Manag; 2017 Apr; 7(2):157-172. PubMed ID: 28540772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of erythropoietin in brain homeostasis, neurodevelopment and neuroprotection].
    Kocsis I; Treszl A; Vásárhelyi B
    Orv Hetil; 2005 Dec; 146(50):2527-32. PubMed ID: 16440497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
    Juul S
    Clin Perinatol; 2004 Mar; 31(1):129-42. PubMed ID: 15183662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotection].
    Detry-Morel M
    J Fr Ophtalmol; 1999 Feb; 22(1):122-34. PubMed ID: 10221206
    [No Abstract]   [Full Text] [Related]  

  • 20. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
    Saver JL
    Rev Neurol Dis; 2008; 5(4):167-77. PubMed ID: 19122569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.